Editor-in-Chief The Journal of Clinical Endocrinology and Metabolism New York, New York 10021
![]() |
Introduction |
---|
![]() ![]() |
---|
However, we have further to go. With the support of The Endocrine Society, JCEM will implement changes in format and content to further stimulate clinical research and to reach out to the whole community of endocrinologists, practitioners as well as academics. We believe that all members of The Society will gain as a result, for it is the interaction between the endocrine clinician and the endocrine research scientist that produces the most important science.
Starting with this issue, JCEM is different in several ways.
First of all, it looks different. In the gray-edged pages at the front of this issue, we have gathered together the papers that we think will be of particular interest to clinical endocrinologists. These include both special invited papers and original studies that may have been hard to locate in our now quite large issues. These articles are also highlighted in the Table of Contents. We hope this makes JCEM more user-friendly to the clinician and more clearly organized than previously for all of our readers.
Second, we are pleased to announce that we have two new Editors on our Board: Drs. Robert A. Kreisberg and Richard J. Mahler. Their special mission is to solicit and shepherd the review of papers that will enhance JCEMs coverage of clinical endocrinology. We hope to augment the number of papers relating to diabetes, lipids, metabolism, and the relationship between hormones and behavior, and to add a fresh perspective for the solicited reviews on topics of current interest. We stress that these papers will receive the same rigorous peer review as all papers published in JCEM.
In conjunction with these initiatives, we will also enlarge the scope of papers accepted for review by JCEM to include updates on legislation that affects endocrinology, updates on drugs, office and HMO management issues, occasional book reviews, and papers that address ethical and legal aspects of endocrine practice. We do not anticipate a radical change in the contents of a typical issue of JCEM, but we hope that such new topics will add to the interest and utility of this journal without at all sacrificing its quality and its impact factor.
Many people contributed to the discussions that shaped these initiatives, and I wish to thank the members of the Publications, Journal Steering, and two ad hoc Committees for their suggestions, and in particular Dr. Robert Vigersky of the Publications Committee and Dr. Lisa Fish of the Clinical Initiatives Committee for their input and leadership. We look forward to your comments as these changes evolve.
HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |